NIH-funded research R21 grant

A new method to control myopia in children using specific light wavelengths

Official title: Pilot test of a novel wavelength-based method to control childhood myopia

Funded at University of Alabama at Birmingham · NIH-10947633 · Data updated 2026-11-12

This study is looking at a new way to help kids with nearsightedness by using special red light to slow down how quickly their eyesight gets worse, and kids who join in will get to try out this light for a little bit each day.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startSeptember 30, 2024
Project endSeptember 29, 2026
Funding year2024
Award (this year)$408,375
NIH project number1R21EY036536-01
Project IDNIH-10947633 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children aged 0-11 years who are experiencing myopia or are at risk of developing it.

Less likely to help

Patients who are not children or those who do not have myopia may not receive any benefit from this research.

What this research studies

This research investigates a novel approach to managing childhood myopia by utilizing specific wavelengths of light to influence eye growth. The study aims to understand how these light cues can effectively slow down the progression of myopia, which is a significant concern for children's vision health. By exploring the effects of narrow-band red light on eye development, the research seeks to provide a more effective treatment option compared to existing methods. Participants may experience brief daily exposure to this light as part of the intervention.

Why it matters

Potential benefit: If successful, this research could lead to a new, effective treatment for slowing the progression of myopia in children, potentially reducing the risk of serious eye conditions later in life.

How similar studies have gone: Previous research has shown promising results using similar wavelength-based approaches to manage myopia, indicating potential for success in this novel application.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Khanal, Safal — University of Alabama at Birmingham
  • Study coordinator: Khanal, Safal

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.